Is Cassava Sciences Stock a Good Investment?
Cassava Sciences Investment Advice | SAVA |
- Examine Cassava Sciences' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Cassava Sciences' leadership team and their track record. Good management can help Cassava Sciences navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Cassava Sciences' business and its evolving consumer preferences.
- Compare Cassava Sciences' performance and market position to its competitors. Analyze how Cassava Sciences is positioned in terms of product offerings, innovation, and market share.
- Check if Cassava Sciences pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Cassava Sciences' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Cassava Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Cassava Sciences is a good investment.
Sell | Buy |
Hold
Market Performance | Modest | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Cassava Sciences Stock
Researching Cassava Sciences' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.94. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Cassava Sciences recorded a loss per share of 1.46. The entity last dividend was issued on the 13th of December 2012. The firm had 1:7 split on the 10th of May 2017.
To determine if Cassava Sciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cassava Sciences' research are outlined below:
| Cassava Sciences had very high historical volatility over the last 90 days | |
| Cassava Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (24.34 M) with loss before overhead, payroll, taxes, and interest of (6.49 M). | |
| Cassava Sciences currently holds about 197.23 M in cash with (116.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cassava Sciences has a poor financial position based on the latest SEC disclosures | |
| Roughly 13.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Cassava Sciences One of the Best Short-Term Stocks to Buy Right Now |
Cassava Sciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cassava Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cassava Sciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Cassava Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Cassava Sciences' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-04-21 | 2021-03-31 | -0.1 | -0.09 | 0.01 | 10 | ||
2020-11-09 | 2020-09-30 | -0.07 | -0.06 | 0.01 | 14 | ||
2020-08-12 | 2020-06-30 | -0.06 | -0.05 | 0.01 | 16 | ||
2021-03-23 | 2020-12-31 | -0.05 | -0.09 | -0.04 | 80 | ||
2019-08-12 | 2019-06-30 | -0.1 | -0.06 | 0.04 | 40 | ||
2012-08-02 | 2012-06-30 | -0.07 | -0.0203 | 0.0497 | 71 | ||
2022-08-03 | 2022-06-30 | -0.43 | -0.48 | -0.05 | 11 | ||
2020-03-26 | 2019-12-31 | -0.13 | -0.08 | 0.05 | 38 |
Know Cassava Sciences' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cassava Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cassava Sciences backward and forwards among themselves. Cassava Sciences' institutional investor refers to the entity that pools money to purchase Cassava Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jane Street Group Llc | 2024-12-31 | 400.2 K | Charles Schwab Investment Management Inc | 2024-12-31 | 319.7 K | Susquehanna International Group, Llp | 2024-12-31 | 280.4 K | Goldman Sachs Group Inc | 2024-12-31 | 278.9 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 266.2 K | Myda Advisors Llc | 2024-12-31 | 169.5 K | Nuveen Asset Management, Llc | 2024-12-31 | 165.5 K | Lmr Partners Llp | 2024-12-31 | 161.5 K | Gallacher Capital Management Llc | 2024-12-31 | 152.9 K | Blackrock Inc | 2024-12-31 | 3.7 M | Vanguard Group Inc | 2024-12-31 | 2.5 M |
Cassava Sciences' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 137.19 M.Market Cap |
|
Cassava Sciences' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.15) | (0.16) | |
| Return On Capital Employed | (0.89) | (0.84) | |
| Return On Assets | (0.15) | (0.16) | |
| Return On Equity | (0.17) | (0.18) |
Determining Cassava Sciences' profitability involves analyzing its financial statements and using various financial metrics to determine if Cassava Sciences is a good buy. For example, gross profit margin measures Cassava Sciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cassava Sciences' profitability and make more informed investment decisions.
Please note, the presentation of Cassava Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cassava Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Cassava Sciences' management manipulating its earnings.
Evaluate Cassava Sciences' management efficiency
Cassava Sciences has return on total asset (ROA) of (0.5718) % which means that it has lost $0.5718 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1719) %, meaning that it created substantial loss on money invested by shareholders. Cassava Sciences' management efficiency ratios could be used to measure how well Cassava Sciences manages its routine affairs as well as how well it operates its assets and liabilities. As of March 23, 2025, Return On Tangible Assets is expected to decline to -0.16. The current year's Return On Capital Employed is expected to grow to -0.84. At present, Cassava Sciences' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 8.4 M, whereas Total Assets are forecasted to decline to about 116.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.14 | 2.99 | |
| Tangible Book Value Per Share | 3.14 | 2.99 | |
| Enterprise Value Over EBITDA | (0.13) | (0.14) | |
| Price Book Value Ratio | 0.75 | 0.46 | |
| Enterprise Value Multiple | (0.13) | (0.14) | |
| Price Fair Value | 0.75 | 0.46 | |
| Enterprise Value | -77.9 M | -74 M |
The leadership approach at Cassava Sciences' fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta (1.24) |
Basic technical analysis of Cassava Stock
As of the 23rd of March, Cassava Sciences shows the Risk Adjusted Performance of 0.0371, mean deviation of 3.6, and Downside Deviation of 3.76. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cassava Sciences, as well as the relationship between them.Cassava Sciences' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cassava Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cassava Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cassava Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cassava Sciences' Outstanding Corporate Bonds
Cassava Sciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Cassava Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Cassava bonds can be classified according to their maturity, which is the date when Cassava Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Cassava Sciences' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Cassava Sciences' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0371 | |||
| Market Risk Adjusted Performance | 0.3197 | |||
| Mean Deviation | 3.6 | |||
| Semi Deviation | 3.58 | |||
| Downside Deviation | 3.76 | |||
| Coefficient Of Variation | 3053.52 | |||
| Standard Deviation | 4.68 | |||
| Variance | 21.9 | |||
| Information Ratio | 0.045 | |||
| Jensen Alpha | 0.1744 | |||
| Total Risk Alpha | 0.4987 | |||
| Sortino Ratio | 0.0561 | |||
| Treynor Ratio | 0.3097 | |||
| Maximum Drawdown | 24.22 | |||
| Value At Risk | (5.49) | |||
| Potential Upside | 8.17 | |||
| Downside Variance | 14.12 | |||
| Semi Variance | 12.81 | |||
| Expected Short fall | (4.40) | |||
| Skewness | 1.12 | |||
| Kurtosis | 1.76 |
| Risk Adjusted Performance | 0.0371 | |||
| Market Risk Adjusted Performance | 0.3197 | |||
| Mean Deviation | 3.6 | |||
| Semi Deviation | 3.58 | |||
| Downside Deviation | 3.76 | |||
| Coefficient Of Variation | 3053.52 | |||
| Standard Deviation | 4.68 | |||
| Variance | 21.9 | |||
| Information Ratio | 0.045 | |||
| Jensen Alpha | 0.1744 | |||
| Total Risk Alpha | 0.4987 | |||
| Sortino Ratio | 0.0561 | |||
| Treynor Ratio | 0.3097 | |||
| Maximum Drawdown | 24.22 | |||
| Value At Risk | (5.49) | |||
| Potential Upside | 8.17 | |||
| Downside Variance | 14.12 | |||
| Semi Variance | 12.81 | |||
| Expected Short fall | (4.40) | |||
| Skewness | 1.12 | |||
| Kurtosis | 1.76 |
Consider Cassava Sciences' intraday indicators
Cassava Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cassava Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Cassava Sciences Corporate Filings
8K | 11th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 3rd of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 26th of November 2024 Other Reports | ViewVerify | |
F3 | 20th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Cassava Stock media impact
Far too much social signal, news, headlines, and media speculation about Cassava Sciences that are available to investors today. That information is available publicly through Cassava media outlets and privately through word of mouth or via Cassava internal channels. However, regardless of the origin, that massive amount of Cassava data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cassava Sciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cassava Sciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cassava Sciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cassava Sciences alpha.
Cassava Sciences Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Cassava Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cassava Sciences Historical Investor Sentiment
Investor biases related to Cassava Sciences' public news can be used to forecast risks associated with an investment in Cassava. The trend in average sentiment can be used to explain how an investor holding Cassava can time the market purely based on public headlines and social activities around Cassava Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cassava Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cassava Sciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Cassava Sciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Cassava Sciences.
Cassava Sciences Maximum Pain Price Across June 20th 2025 Option Contracts
Cassava Sciences' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Cassava Sciences close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Cassava Sciences' options.
Cassava Sciences Corporate Management
| Christopher JD | Company VP | Profile | |
| James MD | Chief Officer | Profile | |
| Michael Zamloot | Senior Operations | Profile | |
| Jaren Landen | Chief Officer | Profile | |
| Michael PharmD | Senior Affairs | Profile | |
| Lindsay Burns | Senior Neuroscience | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cassava Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Cassava Sciences' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.